Discontinuation report NEOSTIGMINE OMEGA
| Report ID | 185181 |
| Drug Identification Number | 02230593 |
| Brand name | NEOSTIGMINE OMEGA |
| Common or Proper name | Neostigmine Methylsulfate Injection USP |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | NEOSTIGMINE METHYLSULFATE |
| Strength(s) | 0.5MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 x 1mL vial / fiole |
| ATC code | N07AA |
| ATC description | PARASYMPATHOMIMETICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-02-20 |
| Remaining supply date | 2021-11-29 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Product is not available. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-02-21 | English | Compare |
| v2 | 2023-02-20 | French | Compare |
| v1 | 2023-02-20 | English | Compare |
Showing 1 to 3 of 3